Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/23/2009WO2009133310A3 Combination of dronedarone with at least one diuretic, and therapeutic use thereof
12/23/2009WO2009132048A3 Treating eosinophilic esophagitis
12/23/2009WO2009129519A3 Benzodiazepine formulation in a polyorthoester carrier
12/23/2009WO2009129511A3 Fluocinolone formulations in a biodegradable polymer carrier
12/23/2009WO2009129428A3 Methods for treating post-operative effects such as spasticity and shivering with clonidine
12/23/2009WO2009129408A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability
12/23/2009WO2009121069A3 Compositions and methods for the preparation of nanoemulsions
12/23/2009WO2009120002A3 Percutaneous preparation containing donepezil as active ingredient for treatment of dementia
12/23/2009WO2009117828A8 Saponin extract from saponaria spp. and uses thereof
12/23/2009WO2009116077A3 Injectable preparation containing a pyridinol derivative
12/23/2009WO2009115666A3 Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria
12/23/2009WO2009115321A8 Imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
12/23/2009WO2009114810A3 Use of ellagitannins as inhibitors of bacterial quorum sensing
12/23/2009WO2009114139A3 Methods, compositions, and kits for treating pain and pruritis
12/23/2009WO2009113108A4 Styrene maleic anhydride based formulation for male contraception and prostate cancer
12/23/2009WO2009111739A3 Treatment of herpes virus related diseases
12/23/2009WO2009111529A3 Method of treating polycystic kidney disease
12/23/2009WO2009110009A3 Opthalmic composition
12/23/2009WO2009105140A3 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
12/23/2009WO2009102427A3 Modified rnai polynucleotides and uses thereof
12/23/2009WO2009097682A8 Anti-influenza compounds
12/23/2009WO2009093188A3 Sequence specific double-stranded dna binding compounds
12/23/2009WO2009090614A3 Derivatives of taxol and closely related compounds
12/23/2009WO2009090251A3 Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives
12/23/2009WO2009088402A3 Identification of bacterial autoinducer and use in treating bacterial pathogenicity
12/23/2009WO2009087005A3 Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
12/23/2009WO2009084041A4 Pharmaceutical compositions of dexibuprofen
12/23/2009WO2009074969A3 Spingosine-1-phosphate, analogues and antagonists for use as medicaments
12/23/2009WO2009071681A3 Rna antagonist compounds for the modulation of bcl-2
12/23/2009WO2009068996A3 Conjugated beta-1,3-linked glucans
12/23/2009WO2009066060A3 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use
12/23/2009WO2009063029A3 Substituted amides, manufacturing and use thereof as medicaments
12/23/2009WO2009060186A8 Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias
12/23/2009WO2009023343A3 Anti-bacterial drug targeting of genome maintenance interfaces
12/23/2009WO2009020534A3 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines
12/23/2009WO2008155140A8 Alkynylpyrimidines as tie2 kinase inhibitors
12/23/2009WO2008153752A3 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/23/2009WO2008152331A9 Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/23/2009WO2008142550A8 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
12/23/2009WO2008115870A8 Induction and/or maintenance of tumor dormancy by disruption of urokinase plasminogen activator receptor-integrin interaction
12/23/2009WO2008114119A3 P38 inhibitors
12/23/2009WO2008107777A3 Improved method for the preparation of desloratadine with reduced levels of organic solvents
12/23/2009WO2008092954A8 Polymorphic forms of a macrocyclic inhibitor of hcv
12/23/2009WO2008091643A3 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy
12/23/2009WO2008083204A3 Modulation of neurogenesis by melatoninergic ligands
12/23/2009WO2008047249A9 Alpha-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
12/23/2009WO2008041053A3 Inhibitors of vegf receptor and hgf receptor signaling
12/23/2009WO2008037937A3 Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings
12/23/2009EP2135959A1 Use of (1R,2S,5R) 1,6-Diazabicyclo [3,2,1]octane-2-carboxamide, 7-oxo-6-(sulfooxy)-, monosodium salt as a diagnostic reagent for detecting serine beta-lactamases
12/23/2009EP2135950A2 Short interfering ribonucleic acid (siRNA) for oral administration
12/23/2009EP2135949A1 MCP-1 binding nucleic acids
12/23/2009EP2135948A2 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/23/2009EP2135871A1 New trinem antibiotics and inhibitors of beta-lactamases
12/23/2009EP2135868A1 Trans-9, 10-dehydroepothilone c and d, analogs thereof and methods of making the same
12/23/2009EP2135867A1 Trans-9, 10-dehydroepothilone C and trans-9, 10-dehydroepothilone D, analogs thereof and methods of making the same
12/23/2009EP2135866A1 New dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis
12/23/2009EP2135864A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/23/2009EP2135623A1 Method of treatment of a BCL-2 disorder using BCL-2 antisense oligomers
12/23/2009EP2135622A2 Compositions for providing an analgesic effect to the skin
12/23/2009EP2135620A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
12/23/2009EP2135615A1 Compositions comprising extracts from sanguinaria or macleaya
12/23/2009EP2135614A1 Intestinal dismicrobism compound having anti-diarrhoea, anti-inflammatory and lactose and lactose derivative intolerance lenitive properties
12/23/2009EP2135613A1 Remedy and diagnostic for mitochondrial dysfunction brain disease
12/23/2009EP2135612A1 Use of ATP in the preparation of a medicament for treating, alleviating and/or enhancing survival of pre-terminal cancer patients
12/23/2009EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy
12/23/2009EP2135610A1 Combination comprising DHODH inhibitors and methotrexate
12/23/2009EP2135609A1 Combinations of nicotinic acetylcholine alpha 7 receptor agonists
12/23/2009EP2135608A1 S-triazolyl alpha -mercaptoacetanilides as inhibitors of HIV reverse transcriptase
12/23/2009EP2135607A1 Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
12/23/2009EP2135606A1 Anti-fatigue agent
12/23/2009EP2135605A2 Therapeutic delivery of carbon monoxide
12/23/2009EP2135604A1 Infusion preparation for cancer patient
12/23/2009EP2135603A2 Compositions and methods for increasing insulin sensitivity
12/23/2009EP2135602A1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
12/23/2009EP2135601A1 Stabilization of amorphous drugs using sponge-like carrier matrices
12/23/2009EP2135600A1 Targeting agent for cancer cell or cancer-associated fibroblast
12/23/2009EP2135517A1 Composition for promotion of bone growth and maintenance of bone health
12/23/2009EP2135512A1 Compound based on malic acid, caffeic acid, a flavan-3-ol and an anthocyane and its use in food and medicine
12/23/2009EP2135507A1 Disinfectant
12/23/2009EP2134736A1 Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer
12/23/2009EP2134720A1 Heterocyclic spiro-compounds
12/23/2009EP2134718A2 Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof
12/23/2009EP2134717A2 Inhibitors of serine proteases
12/23/2009EP2134715A2 O6-alkylguanine-dna alkyltransferase inactivators
12/23/2009EP2134712A1 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro [3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8] naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
12/23/2009EP2134708A1 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
12/23/2009EP2134705A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
12/23/2009EP2134703A1 Amide derivatives as calcium channel blockers
12/23/2009EP2134701A1 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
12/23/2009EP2134696A2 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof
12/23/2009EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/23/2009EP2134692A2 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition
12/23/2009EP2134691A1 Quinolinone derivatives as parp and tank inhibitors
12/23/2009EP2134690A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
12/23/2009EP2134688A1 Fluorinated derivatives of deferiprone
12/23/2009EP2134687A1 Piperazine and piperidine mglur5 potentiators
12/23/2009EP2134686A1 Piperidinones useful in the treatment of inflammation
12/23/2009EP2134685A1 7-nonsubstituted indole mcl-1 inhibitors
12/23/2009EP2134684A2 7-substituted indole mcl-1 inhibitors
12/23/2009EP2134678A2 N-(5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
1 ... 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 ... 7860